Treatment of Intermediate-Risk Pulmonary Embolism

Overview of attention for article published in New England Journal of Medicine, July 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

blogs: 1 blog
twitter: 77 X users

f1000: 1 research highlight platform

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 80 X posts from 77 X users, with an upper bound of 1,409,707 followers.

RT @NEJM: This feature about a patient with intermediate-risk pulmonary embolism offers a case vignette accompanied by two essays, one supp…

@IM_Crit_ No protocol. Admittedly, it’s a grey area but when we lyse, it is usually awaiting ECMO/IR mobilization, so we replace fibrinogen before shoving in big cannulas. We wouldn’t lyse intermediate risk PE, just high risk. Reasoning from my partner Ti…

RT @juanjolopezn: Clinical decisions: Treatment of Intermediate-Risk Pulmonary Embolism @NEJM @asemeve @GT_Trombo @SeparCPulmonar #VTE #pul…

El arte de defender una cosa y la contraria ¿beneficio en subgrupos o riesgo inasumible? Treatment of Intermediate-Risk Pulmonary Embolism @NEJM #fibrinolisis #ETV #TEP https://t.co/GARcDJtZE4 https://t.co/COCz4KmHFc

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 76 additional X posts.